Portrait Eva Camarillo Retamosa

Eva Camarillo Retamosa
Dr. rer. nat.

Postdoktorandin, Department of Rheumatology

Specialties

  • Functional Cell Biology and Genomics
  • High Content Analysis, Spatial Transcriptomics
  • Zellbasierte Therapien und Assays (2D/3D), Zellsortierung und Erstellung von Zellprofilen von Progenitorzellen

Contact

Tel. +41 43 253 31 75
VCard

Further Competencies

  • Cell-based therapies and assays (2D/3D Functional Cell Biology and Genomics
  • High Content Analysis
  • Spatial Transcriptomics
  • Cell-based therapies and assays (2D/3D)
  • Cell sorting and cell profiling of progenitor cells), cell sorting and cell profiling of progenitor cells
  • Regenerative Medicine – Cell Therapy.
  • Bone Marrow Hematopoietic progenitors and Stromal cells.
  • Rheumatoid Arthritis.

Career

Since 2021 Postdoctoral Scientist at the Clinic for Experimental Rheumatology, University Hospital of Zurich, Switzerland
2017-2019 Postdoctoral Scientist Cell therapy and haemotology, Orbsen Therapeutics Ltd., Galway, Ireland
2013-2018 PhD. Cell Biology Regenerative Medicine
PhD Thesis conducted at Orbsen Therapeutics Ltd, Galway, Ireland.
“Bone marrow stromal cell transplantation ameliorates cytopenia caused by depletion FAP-alpha expressing cells.” Marie Skłodowska-Curie ITN-FP7 Project DeCIDE – Birmingham University, UK.
2011-2012 M.Sc. Biology Neuroscience
Master thesis conducted at Prof. Constance Scharff, PhD Laboratory, Freie Universität Berlin, Germany.
“FoxP genes and spiny neuron-dopaminergic receptors in speech disorders” International ERASMUS Program.
2004-2009 Scientist Immunology – Stromal Cell therapy, Cellerix S.A., Madrid, Spain.
2001-2012 B.Sc. Cellular & Molecular Biology.
Universidad Autónoma de Madrid, Spain.
and full time R&D scientist in the pharma industry
2001-2004 Scientist Immunology – Cell therapy. Cellerix S.A., Madrid, Spain
1999-2001 Research associate Immunology, Experimental medicine, Cardiology. Hospital Clínico San Carlos, Madrid, Spain.
1997-1999 Clinical diagnostic laboratory technician. Higher non-University Studies. IES Las Musas, Madrid, Spain.

Most important Memberships

  • EMEUNET – The Emerging EULAR Network-Swiss Society for Rheumatology

Publications (selection)

  1. In Revision process: “Protein atlas of fibroblast specific protein 1 (FSP1)/S100A4”. Bettina Cecilia Marturet Fendt; Astrid Hirschmann; Malgorzata Bruns; Eva Camarillo-Retamosa; Caroline Ospelt; Alexander Vogetseder.
  2. Bone marrow stromal cell transplantation ameliorates cytopenias caused by depletion of FAP expressing cells.bioRxiv. 2020 doi: DOI: 10.1101/2020.11.23.393959
  3. Targeting stromal cell Syndecan-2 reduces breast tumour growth, metastasis and limits immune evasion. IntJ Cancer. 2020 Nov 5. DOI: 10.1002/ijc.33383
  4. Differential coexpression of FoxP1, FoxP2, and FoxP4 in the Zebra Finch (Taeniopygia guttata) song system.2015, J. Comp. Neurol., 523: 1318–1340.
  5. The requirement of IFN mediated Indoleamine 2,3 dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. 2009, Tissue Eng Part A. Oct; 15(10):2795-806.
  6. Obtención de células madre inmortalizadas derivadas de lipoaspirado para su diferenciación hacia diferenteslinajes. Springer Berlin Heidelberg 2007, vol. 18, Pag. 667-670.
  7. DNA immunization with minimalistic expression constructs. 2004, Vaccine 22(13-14): 1709-1716.

Research focus

  • Functional role of the synovial fibroblasts and the bone marrow in arthritides